Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler, et al.
Gastroenterology (2021) Vol. 161, Iss. 1, pp. 66-80.e8
Open Access | Times Cited: 138

Showing 26-50 of 138 citing articles:

Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions
Hui Yang, Lili Xia, Xuanxuan Ye, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 26
Closed Access | Times Cited: 22
Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps
Sean T. Carey, Christopher Bridgeman, Christopher M. Jewell
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 17
Non-Host Factors Influencing Onset and Severity of Celiac Disease
Heather J. Galipeau, Reinhard Hinterleitner, Maureen M. Leonard, et al.
Gastroenterology (2024) Vol. 167, Iss. 1, pp. 34-50
Closed Access | Times Cited: 7
Next-Generation Vaccine Development with Nanomaterials: Recent Advances, Possibilities, and Challenges
Shamitha Shetty, Pablo Cordero Alvarado, Deleah Pettie, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 273-306
Closed Access | Times Cited: 7
Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy
Qi Liu, Guoqiang Chen, Xingchi Liu, et al.
ACS Nano (2024)
Open Access | Times Cited: 6
Tailoring the physicochemical properties of nanomaterials for immunomodulation
Junjie Deng, Jilong Wang, Jiaqi Shi, et al.
Advanced Drug Delivery Reviews (2021) Vol. 180, pp. 114039-114039
Closed Access | Times Cited: 38
Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases
Naomi Benne, Daniëlle ter Braake, Arie Jan Stoppelenburg, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Recent advances of nanotechnology application in autoimmune diseases – A bibliometric analysis
Rendong He, Li Li, Tingjun Zhang, et al.
Nano Today (2022) Vol. 48, pp. 101694-101694
Closed Access | Times Cited: 25
Maresin-2 promotes mucosal repair and has therapeutic potential when encapsulated in thermostable nanoparticles
Jael Miranda, Jennifer Brazil, Aaron H. Morris, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 14
Oxidative Stress-Induced Gastrointestinal Diseases: Biology and Nanomedicines—A Review
Maryam Rezvani
BioChem (2024) Vol. 4, Iss. 3, pp. 189-216
Open Access | Times Cited: 6
Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies
Mazen El Jamal, Farah Shibli
Exploration of Immunology (2024), pp. 189-210
Open Access | Times Cited: 5
Evolution in coeliac disease diagnosis and management
Jason A. Tye‐Din
JGH Open (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 5
Beyond the gluten-free diet: Innovations in celiac disease therapeutics
Sara Massironi, Marianna Franchina, Alessandra Elvevi, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 38, pp. 4194-4210
Closed Access | Times Cited: 5
Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering
Nicole A. J. Krentz, Lonnie D. Shea, Mark O. Huising, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 10, pp. 708-724
Closed Access | Times Cited: 29
Impact of Siglecs on autoimmune diseases
Katarzyna Brzezicka, James C. Paulson
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101140-101140
Open Access | Times Cited: 22
Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut Allergy
Kevin R. Hughes, Michael N. Saunders, Jeffrey J. Landers, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 21
Suppression of Autoimmune Rheumatoid Arthritis with Hybrid Nanoparticles That Induce B and T Cell Tolerance to Self-Antigen
Katarzyna Brzezicka, Britni M. Arlian, Shengyang Wang, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 20206-20221
Closed Access | Times Cited: 21
Celiac disease: New therapies on the horizon
Tessa Dieckman, Frits Koning, Gerd Bouma
Current Opinion in Pharmacology (2022) Vol. 66, pp. 102268-102268
Open Access | Times Cited: 19
Primary Biliary Cholangitis: Personalizing Second-Line Therapies-R1
Cynthia Levy, Christopher L. Bowlus
Hepatology (2024)
Closed Access | Times Cited: 4
Immune therapies in coeliac disease and food allergies: Advances, challenges, and opportunities
Dianne E. Campbell, Sam Mehr, Olivia Moscatelli, et al.
Seminars in Immunology (2025) Vol. 78, pp. 101960-101960
Open Access
Fluorescence Correlation Spectroscopy Monitors the Fate of Degradable Nanocarriers in the Blood Stream
Sascha Schmitt, Anne Huppertsberg, Adrian Klefenz, et al.
Biomacromolecules (2022) Vol. 23, Iss. 3, pp. 1065-1074
Open Access | Times Cited: 18
Review article: Diagnosis of coeliac disease: a perspective on current and future approaches
Robert P. Anderson
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. S1
Closed Access | Times Cited: 18
Clinical Data Do Not Reliably Predict Duodenal Histology at Follow-up in Celiac Disease
Natalie Patel, Daniel A. Leffler, Abdulbaqi Al–Toma, et al.
The American Journal of Surgical Pathology (2023) Vol. 48, Iss. 2, pp. 212-220
Closed Access | Times Cited: 10
Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance
Sydney Kusumoputro, Christian Au, Katie H. Lam, et al.
Nanomaterials (2023) Vol. 14, Iss. 1, pp. 67-67
Open Access | Times Cited: 10
Antigen-specific immunotherapies for autoimmune disease
Jane H. Buckner
Nature Reviews Rheumatology (2024)
Closed Access | Times Cited: 3

Scroll to top